ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1780

Modeling Osteoarthritis Knee Joint in a Compartmentalized Microfluidic System using IPSC-derived Sensory Neurons and human Synovial Fibroblasts

Abdelhak Belmadani1, Dongjun Ren1, Daniel Hoffman2, Nirupa Jayraj1, Paola Pacifico1, Vince Truong3, Patrick Walsh3, Daniela Menichella1, Anna Rapp4, Carla Scanzello5, Rachel Miller6, Richard Miller7 and Anne-Marie Malfait8, 1Northwestern University Chicago, Chicago, IL, 2Rush University, Chicago, IL, 3Anatomic Inc, Minneapolis, MN, 4University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 5University of Pennsylvania, Philadelphia, 6Rush University Medical Center, Chicago, IL, 7Northwestern University, Chicago, 8Rush University Medical Center, Chicago

Meeting: ACR Convergence 2025

Keywords: Fibroblasts, Synovial, Osteoarthritis, pain, Synovitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 28, 2025

Title: (1780–1808) Osteoarthritis & Joint Biology – Basic Science Poster

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Joint pain is one of the most significant clinical hallmarks of knee osteoarthritis (OA). Knee OA is a chronic degenerative disease of the joints characterized by the breakdown of articular cartilage, changes in the subchondral bone (sclerosis) and synovium (synovitis). Uncovering the mechanisms and circuits underlying pain in knee OA remains a major challenge to finding effective and disease-modifying therapy. The synovium is heavily innervated by sensory nerve terminals potentially enabling communication between synovial fibroblasts (sFBs), the predominant cells of the synovium and knee afferents. The aim of this study is to explore mechanisms by which sFBs communicate with knee afferents and how this communication impacts sensory neuron sensitivity in OA knee joints using a microfluidic coculture system.

Methods: In a pilot and feasibility studies, we pioneered a compartmentalized microfluidic system, in which we integrated human iPSCs-derived sensory neurons (SNs) and human sFBs and tested the effects of various stimuli, known to be released by FBs on neurite outgrowth, activity and pain signaling pathways.

Results: Using a two-compartment microfluidic device, we found that hiPSCs–SNs were able to grow neurites towards sFBs within 7 days, where they form extensive connections with cocultured hsFBs. Real time monitoring of the changes in intracellular calcium levels in hiPSC-SNs cocultured with sFBs revealed a dynamic interplay between neuronal activity and sFBs. For example, we have used this system for targeting specific signaling pathways or receptors such as NGF and MRGPRD and study the effects on neurite growth and sensitivity. Similarly, calcium imaging studies in hsFBs from OA patients revealed that the number of FBs with higher baseline signal was significantly increased compared to sFBs from heathy individuals, indicating altered calcium homeostasis, which can impact various cellular processes, including the release of various factors that can activate nociceptors.

Conclusion: This human relevant platform with hiPSCs and hsFBs can be used to explore mechanisms and accelerate the identification of targets for analgesic therapy in joint pain in various health conditions such as in OA.


Disclosures: A. Belmadani: None; D. Ren: None; D. Hoffman: None; N. Jayraj: None; P. Pacifico: None; V. Truong: None; P. Walsh: None; D. Menichella: None; A. Rapp: None; C. Scanzello: None; R. Miller: None; R. Miller: None; A. Malfait: Asahi Kasei Pharma Corporation, 23andMe, Orion, 2.

To cite this abstract in AMA style:

Belmadani A, Ren D, Hoffman D, Jayraj N, Pacifico P, Truong V, Walsh P, Menichella D, Rapp A, Scanzello C, Miller R, Miller R, Malfait A. Modeling Osteoarthritis Knee Joint in a Compartmentalized Microfluidic System using IPSC-derived Sensory Neurons and human Synovial Fibroblasts [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/modeling-osteoarthritis-knee-joint-in-a-compartmentalized-microfluidic-system-using-ipsc-derived-sensory-neurons-and-human-synovial-fibroblasts/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/modeling-osteoarthritis-knee-joint-in-a-compartmentalized-microfluidic-system-using-ipsc-derived-sensory-neurons-and-human-synovial-fibroblasts/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology